NCT04499820Completed
Effect of OMEGA3 Supplementation in Diabetic Retinopathy
Effet d'Une supplémentation Par OMEGA3 Dans la rétinopathie diabétique
Source: ClinicalTrials.gov · Last updated 4 Dec 2025
Brief summary (registry, in English)
The main objective of this study is to evaluate the efficacy at 6 months of omega 3 supplementation on macular capillary density measured in optical coherence tomography angiography in patients with minimal or moderate non proliferative diabetic retinopathy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 3 Jul 2020
- Start date
- 26 Jun 2020
- Primary completion date
- 10 Oct 2024
- Lead sponsor
- Centre Hospitalier Intercommunal Creteil
- Diseases
- Diabetic eye disease
- NCT number
- NCT04499820
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 26 Jun 2020 to the primary completion date, 10 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other retinal pathologies that may interfere with the results (Patients previously treated with anti-VEGF, aflibercept or intra-vitreal corticosteroids, history of glaucoma, vitrectomy, retinal laser, epiretinal membrane), choroidal neo-vascularization, uveitis, retinal vascular occlusion, significant macular edema, macular thickness \> 280 µm, Eyes with spherical equivalent greater than 8 Diopters, OCTA images not interpretable with many artifacts.)
Other illness
- Hypersensitivity to any of the components of Nutrof or Meralut
- History of renal lithiasis
- Kidney failure
- History of hepatopathy
- Intracranial tumor, intracranial hypertension
Age
- \< 18 years old.
Other
- Pregnant or breastfeeding woman
- Taking the antivitamin k
- Known deficit in G6PD-
- Immunosuppression
- Chronic Ethylism
- Refusal to participate
- Patient participating in an intervention study.
Who the study is looking for
- ≥18 years
- For women of childbearing age, an effective method of contraception is introduced and monitored throughout their participation in the study.
- Diabetic microangiopathy: minimal to moderate nonproliferative diabetic retinopathy according to the ETDRS (EarlyTreatment of DiabeticRetinopathyStudy) classification.
- AV \> 6/10
- One eye included. If both are affected, the eye with the poorer perfusion should be included.
- Affiliated to a social security scheme
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chi Creteil Coordinator of this site? Confirm its status | Créteil | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.